Plain-English translation of NCT04111588 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing whether combining a newer type of PET scan (which uses amino acid tracers like 18F-FACBC, 18F-FET, or 11C-MET) with standard MRI imaging can help doctors better diagnose brain tumors and cancers that have spread to the brain. Currently, MRI alone has limitations in determining the grade of a tumor and telling the difference between living cancer cells and scar tissue from treatment. This study hopes to show that adding the amino acid PET scan gives doctors much more accurate information.
Standard MRI scans can miss important details about brain tumors, such as how aggressive they are, exactly how large they are, and whether changes seen after surgery or radiation are scar tissue or returning cancer. This trial exists to determine whether the new imaging approach can solve these problems and help doctors plan better treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive the specialized imaging scans (PET/MRI) as part of your regular care around the time of your scheduled surgery or radiation treatment. Depending on which group you are in, you may have one or more of these scans at baseline and then again a few weeks to months after your treatment. The scans themselves are painless and non-invasive; you simply lie still inside the imaging machine for about an hour. The study involves between 160 participants total across three research centers in Norway.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Norway